Jaffee EM - Search Results

1

Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma.

Wehrli M, Guinn S, Birocchi F, Kuo A, Sun Y, Larson RC, Almazan AJ, Scarfò I, Bouffard AA, Bailey SR, Anekal PV, Montero Llopis P, Nieman LT, Song Y, Xu KH, Berger TR, Kann MC, Leick MB, Silva H, Salas-Benito D, Kienka T, Grauwet K, Armstrong TD, Zhang R, Zhu Q, Fu J, Schmidts A, Korell F, Jan M, Choi BD, Liss AS, Boland GM, Ting DT, Burkhart RA, Jenkins RW, Zheng L, Jaffee EM, Zimmerman JW, Maus MV. Wehrli M, et al. Among authors: jaffee em. Clin Cancer Res. 2024 May 1;30(9):1859-1877. doi: 10.1158/1078-0432.CCR-23-3841. Clin Cancer Res. 2024. PMID: 38393682

2

Development and characterization of a cytokine-secreting pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials.

Jaffee EM, Schutte M, Gossett J, Morsberger LA, Adler AJ, Thomas M, Greten TF, Hruban RH, Yeo CJ, Griffin CA. Jaffee EM, et al. Cancer J Sci Am. 1998 May-Jun;4(3):194-203. Cancer J Sci Am. 1998. PMID: 9612602

3

Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma.

Argani P, Rosty C, Reiter RE, Wilentz RE, Murugesan SR, Leach SD, Ryu B, Skinner HG, Goggins M, Jaffee EM, Yeo CJ, Cameron JL, Kern SE, Hruban RH. Argani P, et al. Among authors: jaffee em. Cancer Res. 2001 Jun 1;61(11):4320-4. Cancer Res. 2001. PMID: 11389052

4

Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).

Argani P, Iacobuzio-Donahue C, Ryu B, Rosty C, Goggins M, Wilentz RE, Murugesan SR, Leach SD, Jaffee E, Yeo CJ, Cameron JL, Kern SE, Hruban RH. Argani P, et al. Clin Cancer Res. 2001 Dec;7(12):3862-8. Clin Cancer Res. 2001. PMID: 11751476

5

Cytokine modified tumor vaccines.

Armstrong TD, Jaffee EM. Armstrong TD, et al. Among authors: jaffee em. Surg Oncol Clin N Am. 2002 Jul;11(3):681-96. doi: 10.1016/s1055-3207(02)00020-0. Surg Oncol Clin N Am. 2002. PMID: 12487062 Review.

6

Mesothelin-specific CD8(+) T cell responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patients.

Thomas AM, Santarsiero LM, Lutz ER, Armstrong TD, Chen YC, Huang LQ, Laheru DA, Goggins M, Hruban RH, Jaffee EM. Thomas AM, et al. Among authors: jaffee em. J Exp Med. 2004 Aug 2;200(3):297-306. doi: 10.1084/jem.20031435. J Exp Med. 2004. PMID: 15289501 Free PMC article.

7

Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response.

Ercolini AM, Ladle BH, Manning EA, Pfannenstiel LW, Armstrong TD, Machiels JP, Bieler JG, Emens LA, Reilly RT, Jaffee EM. Ercolini AM, et al. Among authors: jaffee em. J Exp Med. 2005 May 16;201(10):1591-602. doi: 10.1084/jem.20042167. Epub 2005 May 9. J Exp Med. 2005. PMID: 15883172 Free PMC article.

8

Allergies and the risk of pancreatic cancer: a meta-analysis with review of epidemiology and biological mechanisms.

Gandini S, Lowenfels AB, Jaffee EM, Armstrong TD, Maisonneuve P. Gandini S, et al. Among authors: jaffee em. Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1908-16. doi: 10.1158/1055-9965.EPI-05-0119. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 16103436 Review.

9

OX40 costimulation synergizes with GM-CSF whole-cell vaccination to overcome established CD8+ T cell tolerance to an endogenous tumor antigen.

Murata S, Ladle BH, Kim PS, Lutz ER, Wolpoe ME, Ivie SE, Smith HM, Armstrong TD, Emens LA, Jaffee EM, Reilly RT. Murata S, et al. Among authors: jaffee em. J Immunol. 2006 Jan 15;176(2):974-83. doi: 10.4049/jimmunol.176.2.974. J Immunol. 2006. PMID: 16393983

10

A vascular endothelial growth factor receptor-2 inhibitor enhances antitumor immunity through an immune-based mechanism.

Manning EA, Ullman JG, Leatherman JM, Asquith JM, Hansen TR, Armstrong TD, Hicklin DJ, Jaffee EM, Emens LA. Manning EA, et al. Among authors: jaffee em. Clin Cancer Res. 2007 Jul 1;13(13):3951-9. doi: 10.1158/1078-0432.CCR-07-0374. Clin Cancer Res. 2007. PMID: 17606729

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

312 results

Search Page